Protagonist Therapeutics
PTGX
PTGX
43 hedge funds and large institutions have $91.8M invested in Protagonist Therapeutics in 2017 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 18 increasing their positions, 11 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
10% less capital invested
Capital invested by funds: $103M → $91.8M (-$10.8M)
Holders
43
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$4.52M | |
| 2 | +$3.09M | |
| 3 | +$2.28M | |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$1.41M |
| 5 |
BlackRock
New York
|
+$970K |
Top Sellers
| 1 | -$8.15M | |
| 2 | -$4.44M | |
| 3 | -$2.08M | |
| 4 |
SIM
Spark Investment Management
New York
|
-$403K |
| 5 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$71.3K |